ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Pharmaceutical Intermediate/Fmoc-Lys(Pal-Glu-OtBu)-OH
C46H69N3O8
792.1 g/mol
Pharmaceutical Intermediate

Fmoc-Lys(Pal-Glu-OtBu)-OH

CAS1491158-62-3
Category
Pharmaceutical Intermediate
Compound Class
Peptide
Primary Use
Pharmaceutical Intermediate

Fmoc-Lys(Pal-Glu-OtBu)-OH is a protected amino acid derivative used as a pharmaceutical intermediate. Its structure features a palmitoyl chain, a glutamate residue with a tert-butyl ester protecting group, and an Fmoc-protected lysine backbone, making it suitable for solid-phase peptide synthesis.

Pharmaceutical intermediate for peptide synthesisBuilding block in drug development research

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing Fmoc-Lys(Pal-Glu-OtBu)-OH?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

StrongStructure SimilarSimilarity 0.89

Fmoc-Lys[|A-Glu(OtBu)-C18-OtBu)]-OH

CAS1931109-48-6

research compound

SimilarStructure SimilarSimilarity 0.78

Fmoc-L-Lys[C20-OtBu-L-Glu(OtBu)-AA-AA]-OH

CAS2915356-76-0

pharmaceutical intermediate

ReferenceSame Category

(3R,4S)-tert-Butyl 2-oxo-4-phenyl-3-(triethylsilyloxy)azetidine-1-carboxylate

CAS149198-47-0

pharmaceutical intermediate

ReferenceSame Category

Ojima lactam

CAS149249-91-2

pharmaceutical intermediate

ReferenceSame Category

1-fluoro-2-nitrobenzene

CAS1493-27-2

pharmaceutical intermediate

ReferenceSame Category

3-Boc-aminomethylpyrrolidine

CAS149366-79-0

pharmaceutical intermediate

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-6-[[(4S)-4-(hexadecanoylamino)-5-[(2-methylpropan-2-yl)oxy]-5-oxopentanoyl]amino]hexanoic acid

InChIKey

LQQXBYSAGYOQJW-ZAQUEYBZSA-N

SMILES

CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCCC[C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13)C(=O)OC(C)(C)C

Synonyms (10)
  • Fmoc-Lys(Pal-Glu-OtBu)-OH

Sourcing Fmoc-Lys(Pal-Glu-OtBu)-OH?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→